2Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J]. CMAJ. 2009, 180 (7) : 699-700.
3Ho P. M, Maddox MT, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary" syndromes[ J ]. JAMA, 2009, 301 (9) : 937-944.
4EMEA. Public statement on possible interaction between clopidogrel and proton pump inhibitors[ EB/OL]. 2009-3-29. http :// www. emea. europa, eu/humandocs/PDFs/EPAR/Plavix/32895609en, pdf.
5FDA Drug Safely and Availability. Early Communication about an Ongoing Safety Review of elopidogrel bisulfate ( marketed as Plavix) [ EB/OL]. 2009-5-13. http://www, fda. gov/Drugs/Drug Safety/Postmarket Drug Safety Information for Patients and Providers/Drug Safety Information for Heathcar eProfessionals/ucm079520, htm.
5Savi P,Pereilio JM,Uzabiaga MF,et al.Identification and biological activity of the active metabolite of clopido-grel[J].Thromb Haemost,2000,84(5):891.
6Balamuthusamy S,Arora R.Hematologic adverse effects of clopidogrel[J].Am J Ther,2007,14(1):106.
7CAPRIE Steering Committee.A randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events(CAPRIE)[J].Lancet,1996,348(9038):1329.
